From Neuron‐Centric to Glia‐Centric: How Aging Glial Networks Drive Neurodegenerative Disease
Journal of Neurochemistry · 2026
DOI: 10.1111/jnc.70361 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, 2026. Verfasst von Lívia de Sá Hayashide und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Neuroglia, Aging, Neurons. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Society for Neurochemistry (ISN), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Instituto de Educação Médica (IDOMED).
Abstract (Originalsprache)
The traditional neuron‐centric view of neurodegeneration is being replaced by a glial network–based framework. This shift recognizes that age‐related dysfunction in non‐neuronal cells critically shapes neuronal vulnerability and circuit resilience. Aging, the major risk factor for neurodegenerative diseases, is increasingly associated with the accumulation of senescent glial cells, particularly astrocytes, which emerge as early and active drivers of central nervous system decline. This review highlights astrocytic senescence as a key mechanism linking brain aging to neurodegeneration. Senescent astrocytes exhibit hallmark features including stable cell cycle arrest, mitochondrial dysfunction, and the acquisition of a senescence‐associated secretory phenotype (SASP), which disrupts synaptic integrity, impairs proteostasis, and sustains chronic neuroinflammation. These alterations often precede overt neuronal loss in disorders such as Alzheimer's and Parkinson's disease. We discuss core hallmarks and biomarkers of glial senescence, emphasizing integrative strategies combining functional assays and molecular markers. We further highlight circulating SASP‐related factors and extracellular vesicles as translational indicators of systemic senescence. Finally, we examine emerging senotherapeutic approaches aimed at restoring glial homeostasis, including senolytics, senomorphics, and CAR‐T–based immunotherapies. Targeting glial senescence and interglial communication therefore represents a promising, though complex, paradigm‐shifting avenue for delaying brain aging and mitigating neurodegenerative progression. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
- Centro Nacional de Biologia Estrutural e Bioimagem (CENABIO), Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
- Instituto de Educação Médica (IDOMED), Rio de Janeiro, Rio de Janeiro, Brazil.
Förderung
- International Society for Neurochemistry (ISN)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Instituto de Educação Médica (IDOMED)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
Zitieren
APA
Hayashide, L. S., Pessoa, B., Dias, G., Pontes, B., Pinto, R. S., & Diniz, L. P. (2026). From Neuron‐Centric to Glia‐Centric: How Aging Glial Networks Drive Neurodegenerative Disease. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70361
Vancouver
Hayashide LS, Pessoa B, Dias G, Pontes B, Pinto RS, Diniz LP. From Neuron‐Centric to Glia‐Centric: How Aging Glial Networks Drive Neurodegenerative Disease. Journal of Neurochemistry. 2026. doi:10.1111/jnc.70361
BibTeX
@article{Hayashide2026,
author = {Hayashide, Lívia de Sá and Pessoa, Bruna and Dias, Gustavo and Pontes, Bruno and Pinto, Rafael Serafim and Diniz, Luan Pereira},
title = {From Neuron‐Centric to Glia‐Centric: How Aging Glial Networks Drive Neurodegenerative Disease},
journal = {Journal of Neurochemistry},
year = {2026},
doi = {10.1111/jnc.70361}
}
EUVIMED